Regulacje i polityka gospodarcza · 18/11/1996

FDA Amends Animal Drug Regulations to Remove Approval of Tylosin NADA

The Food and Drug Administration (FDA) is removing approval of a new animal drug application (NADA) for a tylosin Type A medicated article, which was held by Countrymark Cooperative, Inc. The FDA is withdrawing approval of the NADA, which allowed for the use of the medicated article in making a tylosin Type C medicated swine feed.